Total Payments
$489.70
2023 Payments
$45.46
Companies
12
Transactions
35
Medicare Patients
259
Medicare Billing
$25,274
Payment Breakdown by Category
Food & Beverage$489.70 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $489.70 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $96.38 | 7 | $0 (2023) |
| Novo Nordisk Inc | $84.90 | 6 | $0 (2022) |
| Amgen Inc. | $42.56 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $41.31 | 3 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $41.06 | 3 | $0 (2021) |
| PFIZER INC. | $39.18 | 3 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $37.30 | 3 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $34.37 | 2 | $0 (2022) |
| Eisai Inc. | $25.22 | 2 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $22.35 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $45.46 | 3 | ABBVIE INC. ($45.46) |
| 2022 | $154.18 | 11 | Amgen Inc. ($29.24) |
| 2021 | $290.06 | 21 | Novo Nordisk Inc ($58.99) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Respiratory | ||||||
| 08/09/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Respiratory | ||||||
| 05/26/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/10/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Inflammation | ||||||
| 04/19/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Diabetes | ||||||
| 04/06/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Neuroscience | ||||||
| 03/22/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Cardio-renal | ||||||
| 03/09/2022 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2022 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: NEUROLOGY | ||||||
| 02/22/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.36 | General |
| 02/15/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2021 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: NEUROLOGY | ||||||
| 10/20/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $13.39 | General |
| Category: Neurology | ||||||
| 10/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.89 | General |
| 09/21/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/08/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Respiratory | ||||||
| 08/18/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $11.83 | General |
| Category: Neurology | ||||||
| 08/10/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.12 | General |
| 08/03/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 91 | 174 | $41,031 | $10,229 |
| 2022 | 3 | 67 | 100 | $22,493 | $5,537 |
| 2021 | 3 | 67 | 107 | $23,394 | $6,471 |
| 2020 | 2 | 34 | 72 | $12,754 | $3,036 |
Total Patients
259
Total Services
453
Medicare Billing
$25,274
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 96 | $21,570 | $5,375 | 24.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $9,174 | $2,242 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 43 | $6,092 | $1,526 | 25.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 13 | $4,194 | $1,086 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 52 | $11,305 | $2,610 | 23.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 18 | 18 | $7,146 | $1,874 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 30 | $4,043 | $1,053 | 26.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 63 | $12,779 | $3,477 | 27.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 20 | 20 | $7,542 | $2,129 | 28.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 24 | $3,074 | $865.37 | 28.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 57 | $10,917 | $2,600 | 23.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 15 | $1,836 | $436.02 | 23.7% |
About Krissy Wieland, DNP
Krissy Wieland, DNP is a Family healthcare provider based in Independence, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2015. The National Provider Identifier (NPI) number assigned to this provider is 1801263462.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Krissy Wieland, DNP has received a total of $489.70 in payments from pharmaceutical and medical device companies, with $45.46 received in 2023. These payments were reported across 35 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($489.70).
As a Medicare-enrolled provider, Wieland has provided services to 259 Medicare beneficiaries, totaling 453 services with total Medicare billing of $25,274. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Independence, IA
- Active Since 08/28/2015
- Last Updated 01/29/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1801263462
Products in Payments
- VRAYLAR (Drug) $61.31
- BREZTRI (Drug) $41.31
- BELSOMRA (Drug) $41.06
- VYVANSE (Drug) $37.30
- UBRELVY (Drug) $35.07
- SUNOSI (Drug) $34.37
- Aimovig (Biological) $28.07
- Ozempic (Drug) $26.20
- Dayvigo (Drug) $25.22
- PREMARIN (Drug) $24.11
- Kerendia (Drug) $22.35
- ELIQUIS (Drug) $15.07
- Otezla (Drug) $14.49
- ENTRESTO (Drug) $12.60
- NURTEC ODT (Drug) $12.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Independence
Mrs. Laura Badami, Np-C, NP-C
Family — Payments: $9,647
Family $9,647
Lashun Robinson, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $6,558
Family $6,558
Christina Turner
Family — Payments: $6,135
Family $6,135
Mrs. Deborah Truesdell, Aprn, APRN
Family — Payments: $5,900
Family $5,900
Kristen Muscarello, Np, NP
Family — Payments: $4,708
Family $4,708
Mrs. Lacy Mills, Fnp, FNP
Family — Payments: $4,571
Family $4,571